GGrantIndex
Sort

64,565 grants matching drug discovery

International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis

$784,326
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Integrated genomics research in parasitic tropical diseases

$784,316
Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2014 · AI

Genomic Database for Candida Albicans

$784,195
Gavin J Sherlock · Stanford University · R01 · FY2012 · DE

CHEMICAL GENETIC SCREENS FOR TDP-43 MODIFIERS AND ALS DRUG DISCOVERY

$784,074
Universite De Montreal · · FY2011 · Department of Defense

Calprotectin and Antibiotic Activities at the Infection Interface

$784,059
Brian Patrick Conlon · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI

Norovirus 3CL Protease-Based Anti-norovirus Therapeutics

$784,022
Kyeong-Ok Chang · Kansas State University · R01 · FY2014 · AI

Cognitive Computing of Alzheimer's Disease Genes and Risk

$783,998
Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2025 · AG

NINDS CREATE DISCOVERY: Development of dendrimer-N-acetylcysteine for the treatment of neonatal brain injury

$783,954
Kannan Rangaramanujam · Johns Hopkins University · U01 · FY2018 · NS

Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal

$783,771
Matthew G Dorsey · University Of California, San Francisco · U19 · FY2021 · AI

Nonpeptide Kisspeptin Antagonists for PCOS and HPG axis control

$783,766
Stephen F Betz · Crinetics Pharmaceuticals, Inc. · R44 · FY2015 · HD

Sialoglycoproteomic network and target discovery for Alzheimer's disease

$783,746
Lian Li · Emory University · R01 · FY2023 · AG

Prevention of Neonatal Abstinence Syndrome

$783,605
Gary A Peltz · Stanford University · R01 · FY2013 · HD

Neurobehavioral Relations in Senescent Hippocampus

$783,587
Carol A. Barnes · University Of Arizona · R01 · FY2017 · AG

Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications

$783,533
Connie S Lebakken · Stem Pharm, Inc. · R44 · FY2022 · ES

Regulatory landscape of the human genome: comparative and evolutionary analysis.

$783,480
Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2010 · LM

Clinical Pharmacology Training Program

$783,435
Walter K. Kraft · Thomas Jefferson University · T32 · FY2021 · GM

Surface Chemistry Studies with Ion Beams and Lasers

$783,385
Nicholas Winograd · Pennsylvania State Univ University Park · · FY2006 · MPS

Institute for Biomedical and Health Disparities Research

$783,293
Bobby L Wilson · Texas Southern University · G12 · FY2006 · RR

An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities

$783,284
Chia-Ling Phuah · St. Joseph'S Hospital And Medical Center · R01 · FY2025 · AG

Advanced Mass Spectrometry Facility

$783,233
David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK

Systematic Development of Novel, Druggable Cancer Targets

$783,005
Michael E. Berens · Translational Genomics Research Inst · U01 · FY2013 · CA

Using genetic variation to study biology of blood lipids & coronary heart disease

$782,968
Cristen J Willer · University Of Michigan At Ann Arbor · R01 · FY2017 · HL

Mechanisms of Prion Protein Toxicity

$782,968
David A Harris · Boston University Medical Campus · R01 · FY2023 · NS

Drug Development for Prostate Cancer

$782,938
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank

$782,932
William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL